KF
CLVS

Krilogy Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

Krilogy Financial’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-300
Closed -$13K – 793
2017
Q1 		$13K Hold
300
– – ﹤0.01% 490
2016
Q4 		$13K Hold
300
– – ﹤0.01% 490
2016
Q3 		$11K Hold
300
– – ﹤0.01% 520
2016
Q2 		$4K Hold
300
– – ﹤0.01% 637
2016
Q1 		$6K Hold
300
– – ﹤0.01% 527
2015
Q4 		$11K Hold
300
– – 0.01% 253
2015
Q3 		$28K Buy
+300
New +$26K 0.01% 269

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return